 Patients will enter the Screening Period once the informed consentascent and photographic consent process has been completed. Patients with a total body surface area BSA of 2 and 15 atopic dermatitis involvement, in the treatable areas, and who meet all of the inclusion and none of the exclusion criteria will be enrolled. 